| Issue |
Title |
File |
| Vol 11, No 3 (2009) |
Otdalennye rezul'taty khirurgicheskogo lecheniya gastrointestinal'nykh stromal'nykh opukholey zheludochno-kishechnogo trakta |
|
|
Istomin Y.V., Evdokimov M.Y.
|
| Vol 7, No 3 (2005) |
Otkrytaya mnogotsentrovaya programma po otsenke effektivnosti i bezopasnosti kombinirovannoy terapii myustoforanom, tsisplatinom, tamoksifenom patsientov s disseminirovannoy zlokachestvennoy melanomoy |
|
|
Konstantinova M.M., Gershanovich M.L., Akimov M.A., Nosov D.A., Bogdanova N.V.
|
| Vol 3, No 1 (2001) |
Otkrytoe nesravnitel'noe issledovanie gikamtina v kachestve terapii II linii pri rake yaichnikov. Lechenie retsidivov raka yaichnikov gikamtinom - opyt rossiyskikh regionov (predvaritel'naya otsenka neposredstvennykh rezul'tatov) |
|
|
Poddubnaya I.V., Khasanov R.S., Ruchkin V.N., Lazarev A.N., Byakhov M.Y., Vtoraya O.M., Yurchenko V.S.
|
| Vol 14, No 2 (2012) |
Otsenka effektivnosti i perenosimosti abiraterona atsetata (Zitiga) u patsientov s metastaticheskim gormonorezistentnym rakom predstatel'noy zhelezy, u kotorykh otmechalas' progressiya opukholevogo protsessa posle khimioterapii taksanami |
|
|
Gafanov R.A., Ivanov S.A., Fastovets S.V., Isaev T.K.
|
| Vol 11, No 3 (2009) |
Otsenka effektivnostii bezopasnosti fotemustinav monorezhime i v kombinatsii s proizvodnymi platiny(karboplatinom ili tsisplatinom) pri lechenii disseminirovannoy melanomy |
|
|
Konstantinova M.M., Savkova R.F., Demidov L.V., Gorbunova V.A., Kharkevich G.Y., Antimonik N.Y., Merkulov V.N., Simanovich E.E., Ral'chenko K.V., Sbrodov O.V.
|
| Vol 3, No 4 (2001) |
Otsenka toksichnosti protivoopukholevogo preparata gemtsitabina (GEM) |
|
|
Mamedov F.F., Narimanov M.N., Bazin I.S., Efimov O.N., Zharkov S.A., Tryakin A.A., Tyulyandin S.A., Garin A.M.
|
| Vol 26, No 1 (2024) |
Outcomes of extracorporeal partial nephrectomy in patients with malignant tumors: a retrospective and prospective study |
(Rus)
|
|
Matveev V.B., Volkova M.I., Sinitsyna O.R., Kuznetsov K.P., Perlin D.V.
|
| Vol 23, No 2 (2021) |
Outcomes of neoadjuvant chemotherapy in resectable, borderline resectable and locally advanced pancreatic cancer |
(Rus)
|
|
Dalgatov K.D., Semenov N.N., Kozodaeva M.V.
|
| Vol 18, No 1 (2016) |
Outcomes of surgical treatment of advanced gastrointestinal stromal tumors |
(Rus)
|
|
Abouhaidar O.B., Nered S.N., Arkhiri P.P., Nikulin M.P., Stilidi I.S.
|
| Vol 16, No 1 (2014) |
Overcoming immunological tolerance is a way of treating malignant tumors: new perspectives |
|
|
Samoilenko I.V., Kharkevich G.U., Demidov L.V.
|
| Vol 24, No 2 (2022) |
Own experience in the treatment of primary refractory Hodgkin's lymphoma. Case report |
(Rus)
|
|
Gushchina E.E., Vernyuk M.A., Chervontseva A.M., Cherkashina I.V., Khayrullina L.S., Lunin V.V., Fedenko A.A.
|
| Vol 19, No 1 (2017) |
Own experience of treatment by epoetin-α (Eralfon®) of chemotherapy induced anemia |
(Rus)
|
|
Bolshakova S.A., Bychkov Y.M., Kazarova M.V.
|
| Vol 24, No 1 (2022) |
Own Experience of Using Lenvatinib in Patients with Advanced Hepatocellular Carcinoma in Real Clinical Practice based on Moscow City Oncological Hospital №62 |
(Rus)
(Eng)
|
|
Volkonsky M.V., Zhikhorev R.S., Makarkina T.A., Filippova V.M., Vasileva Y.V., Akopyan A.A., Zhelezkova T.A.
|
| Vol 24, No 4 (2022) |
Oxycodone for cancer-related pain in adults (Russian Translation of Cochrane Plain Language Summary (PLS)) |
(Rus)
|
|
Bayazitova R.F.
|
| Vol 3, No 4 (2001) |
Paklitaksel (taksol): novye vozmozhnosti. Ezhenedel'nyy rezhim vvedeniya |
|
|
Voznyy E.K.
|
| Vol 17, No 3 (2015) |
Pamyati Gianni Bonadonna |
|
|
- -.
|
| Vol 12, No 3 (2010) |
Panitumumab v terapii metastaticheskogokolorektal'nogo raka: dannye klinicheskikhissledovaniy, problema kozhnoy toksichnosti |
|
|
Artamonova E.V.
|
| Vol 4, No 4 (2002) |
Parametry serdechno-dykhatel'nogo sinkhronizma i prognoz razvitiya onkologicheskogo zabolevaniya |
|
|
Arkad'eva T.V., Ostrizhnaya N.G.
|
| Vol 19, No 2 (2017) |
PARP inhibitors in female reproductive system cancers |
(Rus)
|
|
Pokataev I.A., Tyulyandin S.A.
|
| Vol 24, No 1 (2022) |
PARP (Poly ADP‐Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancer (Russian Translation of Cochrane Plain Language Summary) |
(Rus)
|
|
Uvarova K.G.
|
| Vol 18, No 2 (2016) |
Passive smoking prevalence among patients of krasnoyarsk regional oncologic dispensary |
(Rus)
|
|
Kutumova O.Y., Kononova L.I., Dobretsova E.A., Shulmin A.B., Korotkova K.M., Rossiyeva T.V.
|
| Vol 15, No 1 (2013) |
Pathogenesis and correction of anemic syndrome in lymphoproliferative disorders patients |
|
|
Romanenko N.A.
|
| Vol 22, No 3 (2020) |
Patient blood management in oncology in the Russian Federation: resolution to improve oncology care. |
(Rus)
|
|
Hofmann A., Aapro M., Fedorova T.A., Zhiburt Y.B., Snegovoy A.V., Kaganov O.I., Ognerubov N.A., Lyadov V.K., Moiseenko V.M., Trofimova O.P., Ashrafyan L.A., Khasanov R.S., Poddubnaya I.V.
|
| Vol 25, No 4 (2023) |
Patient resource to improve the effectiveness of oncological care for the population |
(Rus)
|
|
Kozlov V.A., Samsonov I.V., Mushnikov D.L.
|
| Vol 14, No 3 (2012) |
Pazopanib v lechenii rasprostranennogo pochechno-kletochnogo raka (klinicheskiy sluchay) |
|
|
Savkov R.V.
|
| Vol 8, No 2 (2006) |
Pemetreksed (alimta) |
|
|
Tyulyandin S.A.
|
| Vol 3, No 2 (2001) |
Perifericheskaya neyrotoksichnost' taksotera |
|
|
Shakirova I.N., Lebedeva L.I., Borisova T.A., Meshcheryakov A.A., Setdikov R.A., Gutorov S.L.
|
| Vol 20, No 2 (2018) |
Perioperative chemotherapy for gastric cancer: the current state |
(Rus)
|
|
Lyadov V.K., Pardabekova O.A., Lyadova M.A.
|
| Vol 16, No 3 (2014) |
Personalized approach to HER2-positive advanced breast cancertherapy |
|
|
Stenina M.B.
|
| Vol 25, No 4 (2023) |
Personalized treatment options of refractory and relapsed medulloblastoma in children: literature review |
(Rus)
|
|
Dinikina Y.V., Zheludkova O.G., Belogurova M.B., Spelnikov D.M., Osipov N.N., Nikitina I.L.
|
| Vol 19, No 2 (2017) |
Perspectives of pharmacogenetics approach to personalized tamoxifen therapy |
(Rus)
|
|
Savelyeva M.I., Ignatova A.K., Panchenko Y.S., Urvantseva I.A., Poddubnaya I.V.
|
| Vol 5, No 2 (2003) |
Perspektiva razvitiya khimioterapii s izucheniem etnicheskogo i individual'nogo polimorfizma sistemy tsitokhromov R-450 v Respublike Sakha (Yakutiya) |
|
|
Ivanova F.G.
|
| Vol 9, No 3 (2007) |
Perspektivy ispol'zovaniya Tsetuksimaba pri zlokachestvennykh opukholyakh tolstoy kishki i opukholyakh golovy i shei |
|
|
Khokhlova S.V., Romanov I.S., Gorbunova V.A., Matyakin E.G.
|
| Vol 3, No 3 (2001) |
Perspektivy khimioterapii raka molochnoy zhelezy: vozmozhnosti gemzara po materialam ASCO 2001 g |
|
|
Makarenko N.P.
|
| Vol 14, No 3 (2012) |
Perspektivy primeneniya ademetionina v komplekse intensivnoy terapii bol'nykh s ostroy pechenochnoy nedostatochnost'yu: vzglyad reanimatologa |
|
|
Gromova E.G.
|
| Vol 10, No 3 (2008) |
Pervichnaya mediastinal'nayaV-krupnokletochnaya limfoma: diagnostika, klinicheskaya kartina i lechenie |
|
|
Tumyan G.S., Kovrigina A.M., Kichigina M.Y., Sorokin E.N., Bykov D.A., Kondrat'eva T.T., Probatova N.A., Trofimova O.P., Kolomeytsev O.A., Poddubnaya I.V., Tupitsyn N.N., Larionova V.B., Osmanov D.S.
|
| Vol 5, No 1 (2003) |
Pervichno-mnozhestvennye zlokachestvennye opukholi s porazheniem sosudistoy obolochki glaza |
|
|
Lerner M.Y.
|
| Vol 8, No 4 (2006) |
Pervichnye limfomy kozhi: diagnostika i lechenie |
|
|
Belousova I.E., Krivolapov Y.A.
|
| Vol 3, No 4 (2001) |
Pervichnye MALT-limfomy zheludka u bol'nykh pozhilogo vozrasta |
|
|
Moskalenko O.A., Osmanov D.S., Probatova N.A., Kokosadze N.V., Sholokhova E.N., Kovrigina A.I., Kuvshinov Y.P., Poddubnyy B.K., Poddubnaya I.V.
|
| Vol 13, No 4 (2011) |
Pervichnye nekhodzhkinskielimfomy kostey |
|
|
Sotnikova O.P., Sorokin E.N., Kovrigina A.M., Bykov D.A., Osmanov E.A., Poddubnaya I.V.
|
| Vol 12, No 2 (2010) |
Pervyy opyt luchevogo lecheniyaploskokletochnogo raka orofaringeal'noyzony s radiomodifikatsiey tsetuksimabomi tsisplatinom |
|
|
Boyko A.V., Bolotina L.V., Chernichenko A.V., Gevorkov A.R., Smirnov A.K.
|
| Vol 10, No 3 (2008) |
Pervyy opyt primeneniya alemtuzumaba u bol'nykh khronicheskim limfoleykozom,refrakternykh k fludarabinsoderzhashchim programmam khimioterapii |
|
|
Zagoskina T.P., Malykh O.V., Khorobrykh M.N., Dem'yanova V.I., Isaeva N.V., Grishina I.V.
|
| Vol 23, No 4 (2021) |
Pharmacoeconomic analysis of acalabrutinib in patients with chronic lymphocytic leukemia |
(Rus)
|
|
Nedogoda S.V., Salasyuk A.S., Barykina I.N., Lutova V.O., Popova E.A.
|
| Vol 19, No 1 (2017) |
Pharmacoeconomic aspects of biosimilars |
(Rus)
|
|
Tryakin A.A., Rudakova A.V., Fogt S.N., Vaganov A.S., Tolkacheva D.G.
|
| Vol 19, No 1 (2017) |
Pharmacoeconomic characteristics of ixabepilone (Ixempra) monotherapy in patients with locally advanced and metastatic breast cancer resistant to treatment with anthracyclines, taxanes and capecitabin |
(Rus)
|
|
Kolbin A.S., Mosikyan A.A., Kurilev A.A., Balykina Y.E., Proskurin M.A.
|
| Vol 15, No 4 (2013) |
Pharmacoeconomic potency assignment of targeted agents in the treatment of metastatic colorectal cancer with wild-type Kras |
|
|
Yagudina R.I., Poddubnaya I.V., Kulikov A.U.
|
| Vol 16, No 2 (2014) |
Pharmacoeconomic usefulness of the drug Giotrif® (afatinib) in first-line treatment of locally advanced or metastatic non-small cell lung cancer with a mutation of epidermal growth factor receptor (EGFR) |
|
|
Kolbin A.S., Kurylev A.A., Pavlysh A.V., Proskurin M.A., Balykina Y.Y.
|
| Vol 23, No 2 (2021) |
Pharmacogenetic markers of chemotherapy toxicity in gastrointestinal tumors: a preliminary analysis |
(Rus)
|
|
Fedorinov D.S., Geidarov R.N., Shashkov I.A., Mikhailovich V.M., Lyadova M.A., Pokataev I.A., Lyadov V.K.
|
| Vol 23, No 3 (2021) |
Physical activity interventions for disease‐related physical and mental health during and following treatment in people with non‐advanced colorectal cancer (Russian Translation of Cochrane Plain Language Summary – PLS) |
(Rus)
|
|
Onischuk A.S.
|
| Vol 23, No 3 (2021) |
Physical therapy interventions, other than general physical exercise interventions, in children and adolescents before, during and following treatment for cancer (Russian Translation of Cochrane Plain Language Summary – PLS) |
(Rus)
|
|
Sitnikova V.A.
|
| Vol 23, No 2 (2021) |
PIK3CA mutation: changing the paradigm of HR+ HER2-negative metastatic breast cancer therapy. Review of the Novartis Pharma satellite symposium, held as part of a virtual forum dedicated to the diagnosis and treatment of patients with hormone-dependent HER2-negative advanced breast cancer with a PIK3CA gene mutation. April 23, 2021 |
(Rus)
|
|
Board E.
|
| Vol 23, No 1 (2021) |
Piqray – basic questions at the start: whom to test? whom to treat? how to treat? Event review of the satellite symposium. RUSSCO Big Conference «Breast Cancer» (online). January 29th, 2021 |
(Rus)
|
|
Board E.
|
| Vol 23, No 3 (2021) |
Place of CDK 4/6 and PARP inhibitors in the modern treatment approach of HER2-negative breast cancer |
(Rus)
|
|
Editorial B.
|
| Vol 24, No 4 (2022) |
Place of durvalumab in the treatment of biliary tract cancer: A review |
(Rus)
|
|
Breder V.V., Ledin E.V., Chubenko V.A., Orlova R.V., Petkau V.V., Pokataev I.A.
|
| Vol 20, No 4 (2018) |
Pneumonectomy with carinal resection in patients with non-small cell lung cancer: short and long-term results |
(Rus)
|
|
Dadyev I.A., Davydov M.M., Abdullaev A.G., Kulik I.O., Ambalova Z.A., Akhmedov P.I., Anokhin A.Y., Karasheva B.M.
|
| Vol 6, No 3 (2004) |
Podavlenie superekspressii protoonkogena ornitindekarboksilazy v adenomatoznykh polipakh tolstoy kishki pri naznachenii bol'nym vysokikh doz folievoy kisloty |
|
|
Draudin-Krylenko V.A., Mazurov S.T., Levchuk A.A., Orlov E.N., Poddubnyy B.K., Bukin Y.V.
|
| Vol 14, No 3 (2012) |
Podderzhivayushchaya terapiya nemelkokletochnogo raka legkogo |
|
|
Gutorov S.L., Borisova E.I.
|
| Vol 14, No 3 (2012) |
Podderzhivayushchaya terapiya pri metastaticheskom kolorektal'nom rake: odin iz variantov vybora ili novyy standart lecheniya? |
|
|
Artamonova E.V.
|
| Vol 3, No 3 (2001) |
Podkhody k profilaktike khirurgicheskoy ranevoy infektsii u onkologicheskikh bol'nykh |
|
|
Petukhova I.N., Dmitrieva N.V., Varlan G.V.
|
| Vol 14, No 1 (2012) |
Podvedeny itogi I Vserossiyskoy premiiv oblasti onkologii «IN VITA VERITAS» |
|
|
- -.
|
| Vol 2, No 2 (2000) |
Poliklinicheskiy opyt primeneniya arimideksa u bol'nykh rasprostranennym rakom molochnoy zhelezy v menopauze |
|
|
Potapov S., Kapitonova E.T.
|
| Vol 22, No 3 (2020) |
Polyploid giant cancer cells and their role in the formation of resistance to therapeutic treatment |
(Rus)
|
|
Vartanyan N.L., Pinevich A.A., Bode I.I., Samoylovich M.P.
|
| Vol 25, No 2 (2023) |
Pomalidomide in the management of relapsed/refractory multiple myeloma: A review |
(Rus)
|
|
Semochkin S.
|
| Vol 6, No 4 (2004) |
Populyatsionnyy rakovyy registr kak osnova organizatsii tselevykh (skriningovykh) meditsinskikh osmotrov i kontrolya polnoty registratsii zabolevaniy |
|
|
Cherenkov V.G., Loktionova M.A., Chistyakova T.V.
|
| Vol 21, No 4 (2019) |
Possibilities of epigenetic therapy of acute myeloid leukemias in children |
(Rus)
|
|
Seregin G.Z., Lifshits A.V., Аleskerova G.А., Valiev T.T.
|
| Vol 22, No 1 (2020) |
Possibilities of per-oral transpapillary cholangioscopy in oncological practice |
(Rus)
|
|
Yurichev I.N., Timofeev M.E., Malikhova O.A., Savosin R.S.
|
| Vol 19, No 1 (2017) |
Posterior reversible encephalopathy syndrome in children with hematological and oncology diseases |
(Rus)
|
|
Delyagin V.M., Serdyuk O.A., Balashov D.N., Skvortsova Y.V., Tereshchenko G.V.
|
| Vol 9, No 3 (2007) |
Postmastektomicheskaya limfedema verkhnikh konechnostey: vozmozhnosti konservativnogo lecheniya |
|
|
Myasnikova M.O.
|
| Vol 6, No 1 (2004) |
Pozdnee metastazirovanie granulezokletochnoy opukholi yaichnika |
|
|
Ivanov Y.V., Solov'ev N.A., Markina R.N., Stepanov V.A., Sokolova N.V.
|
| Vol 8, No 1 (2006) |
Pozdnie oslozhneniya terapii bol'nykh limfomoy Khodzhkina |
|
|
Demina E.A., Pylova I.V., Shmakov R.G., Perilova E.E.
|
| Vol 5, No 3 (2003) |
Pravitel'stvo Rossiyskoy Federatsii Rasporyazhenie20 marta 2003 g.№357-R |
|
|
- -.
|
| Vol 18, No 2 (2016) |
Predictive biomarkers in chemotherapy of pancreatic duct adenocarcinoma: rewiew of the literature |
(Rus)
|
|
Kovalenko Z.A., Kekeeva T.V., Lyadov V.K.
|
| Vol 19, No 1 (2017) |
Predictive factors of achievement pathological complete response at neoadjuvant chemotherapy of primary operable breast cancer |
(Rus)
|
|
Pavlikova O.A., Kolyadina I.V., Komov D.V., Vishnevskaya Y.V., Poddubnaya I.V.
|
| Vol 11, No 3 (2009) |
Predoperatsionnaya (neoad\"yuvantnaya) endokrinoterapiya postmenopauzal'nykh bol'nykh rakom molochnoy zhelezy |
|
|
Semiglazov V.F., Semiglazov V.V., Zhil'tsova E.K.
|
| Vol 13, No 4 (2011) |
Predstaviteli Rossiyskogo onkologicheskogosoobshchestva i Komiteta Soveta Federatsiipo sotsial'noy politike i zdravookhraneniyudogovorilis' sovmestno borot'sya s rakommolochnoy zhelezy v Rossii |
|
|
- -.
|
| Vol 10, No 1 (2008) |
Predvaritel'nye rezul'taty induktsionnoy khimioterapii s paklitakselom pri mestnorasprostranennom rake sheyki matki |
|
|
Morkhov K.Y., Kuznetsov V.V., Lebedev A.I., Nechushkina V.M., Zakharova T.I., Tyulyandin S.A.
|
| Vol 4, No 3 (2002) |
Preimushchestva neoad\"yuvantnoy khimioterapii v lechenii ploskokletochnogo raka organov polosti rta i rotoglotki |
|
|
Mudunov A.M., Matyakin E.G., Garin A.M., Podvyaznikov S.O., Azizyan R.I.
|
| Vol 23, No 4 (2021) |
Preliminary assessment of the possibility of using urokinase uPA and urokinase receptor uPAR as universal diagnostic criteria in patients with colorectal and gastric adenocarcinoma |
(Rus)
|
|
Klimovich P.S., Rubina K.A., Mironov N.A., Kakotkin V.V., Oleynikova N.A., Mal`kov P.G., Kubyshkin V.A., Galliamov E.A., Agapov M.A., Semina E.V.
|
| Vol 15, No 1 (2013) |
Preliminary results of an observational program for estimating the duration of bevacizumab therapy in patients with metastatic colorectal cancer in daily clinical practice |
|
|
Poddubnaya I.V., Bobrovskaya E.V., Vladimirova L.Y., Gordeev S.S., Davidenko I.S., Emelyanov S.A., Zharkova O.V., Koroleva I.A., Krasilnikova S.Y., Maikoparova S.C., Malysheva T.A., Modestov A.A., Morozov A.N., Stachenko G.B., Strygina E.A., Tlish E.K., Feoktistova P.S., Chichkanova A.S., Sherman N.Z.
|
| Vol 20, No 1 (2018) |
Pre-operative chemoradiation therapy in complex treatment of patients with locally advanced tumors of the thoracic esophagus |
(Rus)
|
|
Shogenov M.S., Davydov M.M., Allakhverdiyev A.K., Chekini A.K., Filatov A.A., Akhmedov P.I., Serebryanskaya M.V., Korolyeva A.A., Dadyev I.A., Chichikov E.I., Grigorenko V.A., Kozlov N.A., Nazliyev P.B., Malikhova O.A., Tryakin A.A.
|
| Vol 17, No 2 (2015) |
Preparat Gaziva® stanet dostupen dlya terapii patsientov s khronicheskim limfotsitarnym leykozom |
|
|
- -.
|
| Vol 16, No 4 (2014) |
Press release |
|
|
- -.
|
| Vol 16, No 3 (2014) |
Press Release. New data show Giotrif® (afatinib) provided more than one year additional survival for patients with lung cancer associated with the most common type of EGFR mutation (del19) compared to chemotherapy |
|
|
- -.
|
| Vol 17, No 5 (2015) |
Press release | October 21, 2015XII Annual Russian Conference with International Participation "Malignant Lymphomas" Symposium "New perspectives in the treatment of chronic lymphocytic leukemia" |
|
|
- -.
|
| Vol 16, No 4 (2014) |
Press releaseThe resolution of the expert council for targeted therapy of radioactive iodine-refractory differentiated thyroid cancer |
|
|
- -.
|
| Vol 6, No 2 (2004) |
Press-konferentsiya «Novye rezul'taty v endokrinnoy terapii raka molochnoy zhelezy» |
|
|
- -.
|
| Vol 17, No 3 (2015) |
Press-release Combination treatment with Vargatef® and docetaxel contributes to statistically significant tumor reduction in patients with progressive adenocarcinoma of the lung in comparison with docetaxel in monotherapy |
|
|
- -.
|
| Vol 16, No 1 (2014) |
Press-release. The resolution of oncologists of the North-West Federal District: screening for female reproductive system cancers is required |
|
|
- -.
|
| Vol 16, No 2 (2014) |
Press-release. «Merck Serono» announces new retrospective analysis shows significant clinical benefit in overall survival for metastatic colorectal cancer patients with RAS wild-type tumors receiving Erbitux® plus FOLFIRI |
|
|
- -.
|
| Vol 16, No 2 (2014) |
Press-release. «Sanofi» makes a contribution in improving availability of treatment in women with breast cancer in Russia in accordance with international standards |
|
|
- -.
|
| Vol 10, No 3 (2008) |
Press-reliz Novaya era v lechenii raka pochki |
|
|
- -.
|
| Vol 11, No 4 (2009) |
Press-reliz Glioblastoma: novye gorizonty lekarstvennoy terapii |
|
|
- -.
|
| Vol 11, No 4 (2009) |
Press-reliz V Tomske otkrylsya Tsentr ranney diagnostiki opukholey pecheni |
|
|
- -.
|
| Vol 11, No 3 (2009) |
Press-reliz Evropeyskaya komissiya utverdila rasshirenie pokazaniy k primeneniyu Avastina, odobriv ego kombinatsiyus dotsetakselom v kachestve terapii 1-y linii dlya lecheniya rasprostranennogo (metastaticheskogo) raka molochnoy zhelezy |
|
|
- -.
|
| Vol 11, No 3 (2009) |
Press-reliz Na IV Kongresse Rossiyskogo obshchestva onkourologov v Moskve obsudili targetnuyu terapiyu raka pochki i preimushchestva preparata Neksavar |
|
|
- -.
|
| Vol 11, No 4 (2009) |
Press-reliz Na XIII Rossiyskom kongresse onkologov obsudili sostoyanie epidemiologicheskoy programmy skrininga HER2-statusa u zhenshchin, bol'nykh rakom molochnoy zhelezy (RMZh), a takzhe preimushchestvai perspektivy targetnoy terapii preparatami Gertseptin i Avastin |
|
|
- -.
|
| Vol 11, No 3 (2009) |
Press-reliz Novoe protivoopukholevoe soedinenie regorafenib (BAY 73-4506) kompanii «Bayer» obespechilo stabilizatsiyu ili regressiyu u 81% bol'nykh rakom pochki |
|
|
- -.
|
| Vol 10, No 3 (2008) |
Press-reliz Novye vozmozhnosti v lechenii raka pecheni |
|
|
- -.
|
| Vol 15, No 3 (2013) |
Press-reliz Preparat Avastin® odobren v Rossii dlya lecheniya patsientov s metastaticheskim kolorektal'nym rakom v 1 i 2-y liniyakh terapii nepreryvno |
|
|
- -.
|
| Vol 11, No 1 (2009) |
Press-reliz Targetnaya terapiya nemelkokletochnogo raka legkogo: nastoyashchee i budushchee |
|
|
- -.
|
| 701 - 800 of 1319 Items |
<< < 1 2 3 4 5 6 7 8 9 10 11 12 13 14 > >> |
